GlassScriptPhysician profile
Benjamin P Negin
NPI 1366477697
$12,935.15
in general payments reported to CMS, 2019-2025
91 companies · $3,304 in 2025
The $3,304 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,730 · 2020: $364 · 2021: $558 · 2022: $1,961 · 2023: $2,437 · 2024: $2,582 · 2025: $3,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,310 · Education: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,310.16 |
| Education | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $949.90 | 2019-2025 | Lynparza, Calquence, Enhertu |
| Novartis Pharmaceuticals Corporation | $916.95 | 2019-2025 | |
| Pfizer INC. | $714.71 | 2019-2025 | |
| Genentech USA, INC. | $565.06 | 2019-2025 | Tecentriq, Lunsumio, Polivy |
| Glaxosmithkline, LLC. | $468.59 | 2019-2025 | Jemperli, Zejula, Ojjaara |
| Celgene Corporation | $448.75 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| E.R. Squibb & Sons, L.L.C. | $444.83 | 2021-2025 | Opdivo, Opdualag, Eliquis |
| Merck Sharp & Dohme LLC | $399.53 | 2019-2025 | Keytruda, Welireg, Reblozyl |
| Daiichi Sankyo INC. | $385.46 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $348.94 | 2019-2025 | |
| Abbvie INC. | $304.22 | 2019-2025 | |
| Lilly USA, LLC | $282.41 | 2019-2024 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $280.35 | 2019-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $259.48 | 2019-2023 | Imbruvica, Epkinly |
| Astellas Pharma US INC | $258.75 | 2019-2025 | Padcev, Vyloy, Xospata |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $257.10 | 2020-2023 | Padcev, Tukysa, Adcetris |
| Genzyme Corporation | $247.51 | 2019-2025 | |
| Incyte Corporation | $247.47 | 2019-2025 | Jakafi, Zynyz, Monjuvi |
| Janssen Biotech, INC. | $243.88 | 2022-2025 | Tecvayli, Balversa, Erleada |
| Gilead Sciences, INC. | $242.80 | 2019-2025 | Trodelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $237.13 | 2019-2025 | Alunbrig, Fruzaqla, Ninlaro |
| Genmab U.S., INC. | $208.64 | 2022-2025 | Tivdak |
| Sobi, INC | $183.73 | 2022-2025 | |
| Kite Pharma, INC. | $181.04 | 2019-2025 | Yescarta |
| Immunocore Limited | $176.30 | 2024-2025 | Kimmtrak |
| Karyopharm Therapeutics INC. | $172.82 | 2022-2025 | Xpovio |
| Pharmacosmos Therapeutics INC. | $164.65 | 2022-2025 | Monoferric |
| Array Biopharma INC | $161.86 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Exelixis INC. | $160.64 | 2019-2025 | Cabometyx |
| Janssen Pharmaceuticals, INC | $152.49 | 2019-2024 | Xarelto |
| Rigel Pharmaceuticals, INC. | $126.46 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Regeneron Healthcare Solutions, INC. | $120.00 | 2019-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.18 | 2020-2025 | Gilotrif |
| Ipsen Biopharmaceuticals, INC | $108.46 | 2019-2025 | Tazverik, Onivyde |
| Amgen INC. | $105.60 | 2019-2023 | Xgeva, Nplate, Blincyto |
| Beigene USA, INC. | $103.01 | 2022-2025 | Brukinsa, Tevimbra |
| Stemline Therapeutics INC. | $95.78 | 2019-2025 | Orserdu |
| Tersera Therapeutics LLC | $91.34 | 2019-2025 | Zoladex, Xermelo |
| Novocure INC. | $79.42 | 2025 | Optune Gio, Optune Lua (Novottf-200t) |
| Morphosys, US INC. | $77.77 | 2022-2024 | Monjuvi |
| Alexion Pharmaceuticals, INC. | $76.80 | 2023-2024 | Ultomiris |
| Aveo Pharmaceuticals, INC. | $76.62 | 2022-2025 | |
| Blueprint Medicines Corporation | $73.97 | 2022-2024 | Ayvakit |
| Organon LLC | $72.85 | 2021-2024 | |
| Emd Serono, INC. | $72.22 | 2021-2025 | |
| Tempus Ai, INC | $68.69 | 2024-2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $65.42 | 2019-2025 | |
| Apellis Pharmaceuticals, INC. | $63.96 | 2023-2024 | Empaveli |
| Dova Pharmaceuticals | $62.77 | 2019-2020 | |
| Invivyd INC | $61.36 | 2025 | Pemgarda |
| Springworks Therapeutics, INC. | $59.25 | 2025 | Ogsiveo, Gomekli |
| Taiho Oncology, INC. | $54.06 | 2019-2024 | |
| Mirati Therapeutics, INC. | $53.69 | 2023-2024 | Krazati |
| Tolmar, INC. | $51.65 | 2023-2025 | Rubraca, Eligard |
| Tesaro, INC. | $49.91 | 2019 | |
| Servier Pharmaceuticals LLC | $48.58 | 2022-2025 | |
| Adc Therapeutics America, INC. | $41.67 | 2024-2025 | |
| Secura Bio, INC. | $40.41 | 2019-2023 | Copiktra |
| Pharmaand Gmbh | $35.96 | 2025 | Rubraca |
| Agios Pharmaceuticals, INC. | $35.37 | 2023-2024 | Pyrukynd |
| Spectrum Pharmaceuticals INC. | $35.01 | 2023-2025 | Rolvedon |
| Beone Medicines USA, INC. | $33.29 | 2025 | Brukinsa |
| Geron Corporation | $32.81 | 2024-2025 | Rytelo |
| Pharmaessentia USA Corporation | $32.28 | 2024 | Besremi |
| Acrotech Biopharma INC. | $31.96 | 2022-2025 | Ryzneuta |
| Amneal Pharmaceuticals LLC | $31.26 | 2025 | Alymsys |
| Mylan Institutional INC. | $30.37 | 2019 | |
| Foundation Medicine, INC. | $29.69 | 2019 | |
| Verastem, INC. | $28.62 | 2019-2020 | |
| Fresenius Kabi USA, LLC | $28.29 | 2022 | |
| Shield Therapeutics INC | $27.98 | 2025 | |
| Celltrion USA INC. | $27.97 | 2024-2025 | Vegzelma |
| Deciphera Pharmaceuticals INC. | $26.92 | 2021-2022 | |
| Aadi Bioscience, INC. | $21.73 | 2025 | Fyarro |
| Digestive Care, INC. | $20.75 | 2022 | |
| Puma Biotechnology, INC. | $19.60 | 2025 | |
| Octapharma USA, INC. | $19.03 | 2019 | |
| Fennec Pharmaceuticals, INC. | $18.21 | 2025 | Fyarro |
| Cti Biopharma Corp. | $17.38 | 2022 | |
| Dendreon Pharmaceuticals LLC | $16.83 | 2023 | Provenge |
| Coherus Oncology, INC. | $16.19 | 2023 | |
| Helsinn Therapeutics (U.S.), INC. | $15.98 | 2025 | Akynzeo |
| Verity Pharmaceuticals INC. | $15.28 | 2023 | Trelstar |
| Accord Healthcare, INC. | $15.14 | 2023 | |
| Eusa Pharma (US) LLC | $14.96 | 2022 | |
| Aurobindo Pharma USA, INC. | $14.49 | 2019 | |
| Clinigen, INC. | $14.13 | 2019 | |
| Alnylam Pharmaceuticals INC. | $14.04 | 2025 | Givlaari |
| Amag Pharmaceuticals, INC. | $13.18 | 2019 | |
| Advanced Accelerator Applications | $12.85 | 2020 | |
| Clovis Oncology, INC. | $10.71 | 2021 |
Drugs and devices associated with these payments
Enhertu $371Padcev $336Lynparza $330Tukysa $236Keytruda $229Nubeqa $193Ibrance $191Reblozyl $184Zejula $179Jemperli $179Kisqali $178Kimmtrak $176Tivdak $167Ojjaara $158Jakafi $148Inlyta $147Calquence $145Xtandi $141Imfinzi $136Monoferric $135Braftovi $134Mektovi $134Imbruvica $131Lenvima $128Xpovio $127Venclexta $126Opdivo $126Talzenna $125Xofigo $123Fabhalta $117Scemblix $116Vonjo $113Pluvicto $107Stivarga $107Vitrakvi $107Yescarta $97.89Verzenio $94.90Opdualag $92.49Krazati $83.65Lorbrena $81.16Orserdu $80.70Lupron Depot $79.60Ultomiris $76.80Libtayo $75.85Brukinsa $75.70Rubraca $71.92Welireg $71.27Tavalisse $70.60Rezlidhia $70.60Tecentriq $69.25Xt Cdx $68.69Tazverik $66.70Xarelto $64.90Trodelvy $64.31Tecvayli $64.05Empaveli $63.96Polivy $63.24Lunsumio $63.24Gazyva $63.24Pemgarda $61.36Cabometyx $59.02Epkinly $58.89Alunbrig $58.77Promacta $55.91Doptelet $54.61Optune Gio $54.20Optune Lua (Novottf-200t) $52.32Eligard $51.65Ayvakit $51.15Zepzelca $50.82Adcetris $49.55Elrexfio $48.98Piqray $48.96Jaypirca $47.06Monjuvi $47.06Columvi $46.83Pomalyst $45.20Sarclisa $44.96Orgovyx $44.05Jevtana $43.71Inqovi $43.08Lonsurf $43.08Balversa $42.08Erleada $42.08Fyarro $39.94Fruzaqla $38.26Ogsiveo $38.05Tasigna $37.54Mekinist $37.34Eliquis $36.86Kadcyla $35.85Phesgo $35.85Perjeta $35.85Pyrukynd $35.37Rolvedon $35.01Comirnaty $34.97Bosulif $33.51Rituxan Hycela $33.06Rytelo $32.81Injectafer $32.38
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Negin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.